The UAE has become the second country worldwide to approve Itvisma, a groundbreaking gene therapy for spinal muscular atrophy ...
Quebec, Canada, December 20th, 2025, FinanceWireInternational clinician and integrative health researcher Oxana Ali has ...
U.S. Health Secretary Robert F. Kennedy Jr. on Tuesday added two rare genetic disorders, Duchenne Muscular Dystrophy and ...
Akhilesh Gaharwar, a biomedical engineer and one of the researchers on the project at Texs A&M, said they have found a way to ...
Determining which patients should receive the treatment will still require individual risk-benefit assessments, experts say.
Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...
Dubai, UAE: The Emirates Drug Establishment (EDE) has announced the approval of Itvisma™ (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular ...
Edex Live on MSN
UAE approves gene replacement therapy for wider SMA age group
The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular atrophy (SMA) ...
Emirates News Agency on MSN
UAE approves gene replacement therapy for new age group in spinal muscular atrophy patients
The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that ...
Aging taps us on the shoulder in many ways: wrinkles, thinning hair, loss of flexibility, slowing of the brain. But the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback